Weight loss drugs: €400m tablet factory to be built in Ireland
By John Campbell
Published on March 2, 2026.
Novo Nordisk, the maker of the weight-loss drug Wegovy, plans to invest over €400m to upgrade its facility in Athlone, County Westmeath, Ireland. The investment is seen as a historic milestone by the company and its employees. The drug was approved for sale in the United States in January and is expected to be approved on other markets soon.
Read Original Article